Patents by Inventor Schwe Fang Pong

Schwe Fang Pong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo-containing heterocyclic compounds, their compositions and uses
    Patent number: 6552033
    Abstract: The subject invention involves compounds having the structure: wherein each R1 is independently alkyl, aryl, or heterocycle; each R2-R7 is independently hydrogen or other substituent; B is nil and n is 0-3, or B is ethenyl and n is 0-1; and pharmaceutically acceptable forms thereof. The subject invention also involves pharmaceutical compositions containing such compounds, and methods for treating or preventing diseases or disorders using such compounds.
    Type: Grant
    Filed: February 13, 2002
    Date of Patent: April 22, 2003
    Assignee: The Procter & Gamble Co.
    Inventors: Song Liu, David Edward Portlock, Schwe Fang Pong
  • Imidazo-benzazepine compounds, their compositions and uses
    Patent number: 6476020
    Abstract: The subject invention involves compounds having the structure: wherein the C&agr;—N&bgr;, C5-C6, and C6-C7 bonds are each single or double bonds, except that both C5-C6, and C6-C7 are double bonds; R1 is selected from hydrogen, alkyl, aryl, and heterocycle; R2-R15 are independently selected from hydrogen and other substituents; and pharmaceutically-acceptable forms thereof. The subject invention also involves pharmaceutical compositions containing such compounds, and methods for treating or preventing diseases and disorders using such compounds.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: November 5, 2002
    Assignee: The Procter & Gamble Company
    Inventors: Song Liu, David Edward Portlock, Schwe Fang Pong
  • Imidazo-isoquinoline compounds, their compositions and uses
    Patent number: 6159985
    Abstract: The subject invention involves compounds having the structure: wherein the C.sub..alpha. --N.sub..beta. and C.sub.5 -C.sub.6 bonds are independently single or double bonds, R1 is selected from alkyl, aryl, and heterocycle; R2-R13 are independently selected from hydrogen and other substituents; and pharmaceutically-acceptable salts thereof. The subject invention also involves pharmaceutical compositions containing such compounds, and methods for treating or preventing diseases and disorders using such compounds.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: December 12, 2000
    Assignee: The Procter & Gamble Company
    Inventors: Song Liu, David Edward Portlock, Schwe Fang Pong